Find the latest pharmaceutical market place for formulations enquiry about Insulin on PharmaCompass.com.

Various Finished Dosage Formulations needed in Mexico [ENA13437]

A company that offers comprehensive medical services, from equipping hospitals, providing maintenance to medical equipment and making tests for various diseases is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with GMP.
1. Sitagliptin (50 mg) + Metformin (850 mg) Tablets. The required pack size is 56 Tablets per box.
2. Recombinant Origin NPH Insulin (100 UI in 10 ml) Vials.
3. Recombinant Origin Rapid-Acting Human Insulin (100 UI in 10 ml) Vials.
4. Enoxaparin Sodium (60 mg) Prefilled Syringes with and without safety devices.

Reply

26 Apr 2022

Insulin (100 IU/ ml) Prefill needed in Iran [ENA11570]

Sana Pharma, a company that deals in the import & distribution of various pharmaceutical products is looking for suppliers of Insulin (100 IU/ ml) Prefill for commercial purpose. The initial required quantity is 1,000,000 units & later 10,000,000 units/ annum. Interested suppliers can contact them via their email: business@sanapharma.ir.

Reply

05 Oct 2021

Enquiry// Novolin GE and Actrapid (8 vials of 10 different batch no.) needed in India [ENA00839]

One of leading custom research and manufacturing organization in India is looking for suppliers of following products for R&D purposes:
1. Novolin GE 80 vials (8 vials of 10 different batch no.) 100 units/ml Source: Canada
2. Actrapid 80 vials (8 vials of 10 different batch no.) 100 units/ml Source: Europe

Reply

19 Apr 2018

Enquiry// Contract Manufacturers of Insulin auto-injectors/pens needed in Europe [ENA00766]

A leading company based in Argentina is looking for Europe based contract manufacturers of Insulin auto-injectors/pens for supply to Argentina.

Reply

16 Mar 2018

Enquiry// Human Insulin formulations needed in Argentina [ENA00690]

A leading company based in Argentina is looking for suppliers/manufacturers of Human Insulin formulations. The finished product must be manufactured in a country with high sanitary surveillance, as per their health authorities (France, England, Germany, Italy, Spain, Sweden, Israel, Japan, USA, Canada).

Reply

03 Feb 2018

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.